10.1002/adsc.202000566
Advanced Synthesis & Catalysis
1.60 (m, 3H), 1.55 (s, 6H), 1.49 – 1.32 (m, 5H), 1.34 –
1.15 (m, 2H), 1.10 – 0.83 (m, 3H). 13C{1H} NMR (50
MHz, CDCl3) δ 148.2, 147.0, 145.3, 134.8, 123.2, 90.6,
82.7, 64.7, 60.3, 60.0, 49.8, 39.4, 38.2, 36.2, 32.5, 25.6,
23.8, 23.1, 23.0. HRMS (ESI-TOF) m/z [M+H]+ calcd for
C20H29N2O 313.2274 ; Found 313.2275.
NMR (50 MHz, CDCl3) δ 131.9, 128.4, 127.9, 123.9, 91.4,
85.1, 65.9, 49.5, 40.7, 23.9, 23.7.[70]
1-(1-(phenylethynyl)cyclohexyl)pyrrolidine
(4e):
Prepared according to the general procedure and obtained
as an orange/yellow oil in 91% yield (461 mg, 1.82 mmol).
1H NMR (200 MHz, CDCl3) δ 7.44 (dd, J = 6.7, 3.1 Hz,
2H), 7.30 (m, 3H), 2.82 (t, J = 5.9 Hz, 4H), 2.13 – 1.94 (m,
2H), 1.91 – 1.41 (m, 12H, overlapping peaks). 13C{1H}
NMR (50 MHz, CDCl3) δ 131.7, 128.1, 127.6, 123.6, 90.3,
86.1, 59.3, 47.0, 37.8, 25.7, 23.5, 23.0.[76]
1-(1-((4-chlorophenyl)ethynyl)cyclohexyl)pyrrolidine
(4s): Prepared according to the general procedure and
obtained as pale yellow crystals in 77% yield (440 mg,
1.53 mmol). 1H NMR (200 MHz, CDCl3) δ 7.40 – 7.25 (d,
J = 8.5 Hz, 2H), 7.22 – 7.14 (d, J = 8.5 Hz, 2H), 2.76 –
2.67 (t, J = 5.8 Hz, 4H), 2.00 – 1.88 (d, J = 8.0 Hz, 2H),
1.81 – 1.38 (m, 12H, overlapping peaks). 13C{1H} NMR
(50 MHz, CDCl3) δ 133.8, 133.1, 128.6, 122.4, 91.9, 85.2,
59.5, 47.2, 38.0, 25.9, 23.7, 23.2. HRMS (ESI-TOF) m/z
[M+H]+ calcd for C18H23ClN 288.1514; Found 288.1510.
1-(3-methyl-1-phenylhex-1-yn-3-yl)pyrrolidine
(4g):
Prepared according to the general procedure and obtained
as an orange/brown oil in 48% yield (232 mg, 0.96 mmol).
1H NMR (200 MHz, CDCl3) δ 7.45 – 7.36 (m, 2H), 7.28 –
7.25 (m, 3H), 2.79 (t, J = 5.4 Hz, 4H), 1.85 – 1.74 (m, 4H),
1.73 – 1.47 (m, 4H), 1.43 (s, 3H), 0.95 (t, J = 7.1 Hz, 3H).
13C{1H} NMR (50 MHz, CDCl3) δ 132.0, 128.4, 127.9,
123.8, 91.5, 84.7, 58.3, 48.0, 44.0, 26.1, 23.9, 18.0,
14.8.[76]
1-(1-((4-chlorophenyl)ethynyl)cyclohexyl)piperidine
(4t): Prepared according to the general procedure and
obtained as pale yellow crystals in 64% yield (380 mg,
1.26 mmol). 1H NMR (200 MHz, CDCl3) δ 7.39 – 7.29 (d,
J = 8.7 Hz, 2H), 7.26 – 7.19 (d, J = 8.7 Hz, 2H), 2.63 (t, J
= 5.0, 3.6 Hz, 4H), 2.03 (d, J = 9.9 Hz, 2H), 1.53 (m, 14H,
overlapping peaks). 13C{1H} NMR (50 MHz, CDCl3) δ
133.8, 133.1, 128.7, 122.5, 92.1, 85.2, 59.5, 47.4, 35.9,
26.8, 25.9, 24.9, 23.3. HRMS (ESI-TOF) m/z [M+H]+
calcd for C19H25ClN 302.1670; Found 302.1670.
1-(3-ethyl-1-phenylpent-1-yn-3-yl)pyrrolidine
(4h):
Prepared according to the general procedure and obtained
1
as a yellow oil in 32% yield (154 mg, 0.64 mmol). H
NMR (200 MHz, CDCl3) δ 7.41 (dd, J = 6.7, 3.1 Hz, 2H),
7.32 – 7.23 (m, 3H), 2.78 (s, 4H), 1.88 – 1.66 (m, 8H,
overlapping peaks), 0.96 (t, J = 7.4 Hz, 6H). 13C{1H} NMR
(50 MHz, CDCl3) δ 131.9, 128.3, 127.7, 123.8, 91.5, 85.0,
62.2, 47.6, 29.0, 23.7, 8.3.[81]
1-(phenylethynyl)-N,
N-dipropylcyclohexan-1-amine
(4zc): Prepared according to the general procedure and
obtained as a pale - yellow oil in 61% yield (346 mg, 1.22
mmol). 1H NMR (200 MHz, CDCl3) δ 7.54 – 7.37 (m, 2H),
7.34 – 7.20 (m, 3H), 2.75 – 2.51 (t, J = 7.8 Hz, 4H), 2.23 –
1.99 (d, J = 11.2 Hz, 2H), 1.78 – 1.37 (m, 12H,
overlapping peaks), 1.02 – 0.70 (t, J = 7.3 Hz, 6H).
13C{1H} NMR (50 MHz, CDCl3) δ 131.8, 128.4, 127.7,
124.3, 93.3, 85.1, 59.8, 52.7, 37.5, 29.9, 26.0, 23.5, 23.3,
12.2. HRMS (ESI-TOF) m/z [M+H]+ calcd for C20H30N
284.2373; Found 284.2374.
1-(4-(phenylethynyl)decan-4-yl)pyrrolidine
(4i):
Prepared according to the general procedure and obtained
1
as a yellow oil in 68% yield (424 mg, 1.36 mmol). H
NMR (200 MHz, CDCl3) δ 7.41 (dd, J = 6.6, 3.1 Hz, 2H),
7.32 – 7.24 (m, 3H), 2.76 (s, 4H), 1.88 – 1.58 (m, 8H,
overlapping peaks), 1.51 – 1.18 (m, 10H), 1.00 – 0.77 (m,
6H). 13C{1H} NMR (50 MHz, CDCl3) δ 131.7, 128.2,
127.6, 123.7, 91.6, 84.7, 61.3, 47.5, 39.4, 37.1, 31.9, 29.8,
23.6, 22.8, 17.2, 14.6, 14.2.[81]
Characterization data for known compounds
1-(2-(4-methoxyphenyl)-4-phenylbut-3-yn-2-
yl)pyrrolidine (4j): Prepared according to the general
procedure and obtained as a yellow oil in 34% yield (208
1-(1-(phenylethynyl)cyclohexyl)piperidine
(4a):
1
Prepared according to the general procedure and obtained
mg, 0.68 mmol). H NMR (200 MHz, CDCl3) δ 7.76 –
1
as a yellow oil in 97% yield (519 mg, 1.94 mmol). H
7.63 (d, J = 8.7 Hz, 2H), 7.59 – 7.46 (dd, J = 2.7, 6.1 Hz,
2H), 7.41 – 7.29 (m, 3H), 6.95 – 6.83 (d, J = 8.7 Hz, 2H),
3.91 – 3.76 (s, 3H), 2.83 – 2.69 (m, 2H), 2.69 – 2.54 (m,
2H), 1.91 – 1.75 (m, 4H), 1.78 – 1.69 (s, 3H). 13C{1H}
NMR (50 MHz, CDCl3) δ 158.9, 138.2, 132.1, 128.6,
128.2, 127.8, 123.7, 113.6, 89.9, 87.4, 62.3, 55.5, 48.7,
32.6, 24.1.[68]
NMR (200 MHz, CDCl3) δ 7.47 – 7.36 (m, 2H), 7.28 –
7.23 (m, 3H), 2.66 (s, 4H), 2.11– 2.05 (m, 2H), 1.83 – 1.34
(m, 14H, overlapping peaks). 13C{1H} NMR (50 MHz,
CDCl3) δ 131.9, 128.4, 127.8, 124.0, 91.1, 86.3, 59.5, 47.4,
36.0, 26.9, 26.0, 25.0, 23.3.[63,70,76]
1-(1-(phenylethynyl)cyclopentyl)piperidine
(4b):
Prepared according to the general procedure and obtained
1-(2-(4-chlorophenyl)-4-phenylbut-3-yn-2-
1
as a yellow oil in 67% yield (339 mg, 1.34 mmol). H
yl)pyrrolidine (4k): Prepared according to the general
procedure and obtained as a yellow oil in in 42% yield
NMR (200 MHz, CDCl3) δ 7.41 (dd, J = 6.5, 3.2 Hz, 2H),
7.31 – 7.25 (m, 3H), 2.65 – 2.62 (m, 4H), 2.13 – 2.10 (m,
2H), 1.87 – 1.44 (m, 12H, overlapping peaks). 13C{1H}
NMR (50 MHz, CDCl3) δ 131.9, 128.4, 127.8, 124.0, 91.6,
85.4, 67.7, 50.5, 40.1, 26.4, 24.7, 23.6.[70]
1
(260 mg, 0.84 mmol). H NMR (200 MHz, CDCl3) δ 7.87
– 7.71 (d, J = 8.3 Hz, 2H), 7.66 – 7.53 (m, 2H), 7.47 – 7.30
(m, 5H, overlapping peaks), 2.87 – 2.75 (m, 2H), 2.72 –
2.59 (m, 2H), 1.91 – 1.79 (m, 4H), 1.82 – 1.70 (s, 3H).
13C{1H} NMR (50 MHz, CDCl3) δ 144.7, 133.0, 132.2,
128.6, 128.5, 128.4, 128.2, 123.5, 89.1, 87.8, 62.5, 48.7,
32.8, 24.2.[68]
1-(1-(phenylethynyl)cycloheptyl)pyrrolidine
(4c):
Prepared according to the general procedure and obtained
1
as a yellow oil in 73% yield (390 mg, 1.46 mmol). H
NMR (200 MHz, CDCl3) δ 7.42 (dd, J = 6.6, 3.1 Hz, 2H),
7.28 (dd, J = 6.6, 2.7 Hz, 3H), 2.79 (t, J = 6.0 Hz, 4H),
1-(1-(m-tolylethynyl)cyclohexyl)piperidine
Prepared according to the general procedure and obtained
(4m):
1
2.10 – 1.83 (m, 4H, overlapping peaks), 1.78 (p, J = 3.2 Hz, as a yellow oil in 81% yield (456 mg, 1.64 mmol). H
4H), 1.71 – 1.46 (m, 8H, overlapping peaks). 13C{1H}
NMR (50 MHz, CDCl3) δ 132.0, 128.4, 128.0, 123.7, 91.4,
85.3, 63.3, 48.2, 40.0, 28.2, 24.0, 22.4.[70]
NMR (200 MHz, CDCl3) δ 7.25 – 7.03 (m, 4H), 2.77 –
2.61 (t, J = 3.0, 3.9 Hz, 4H), 2.36 – 2.30 (s, 3H), 2.15 –
2.03 (d, J = 12.1 Hz, 2H), 1.85 – 1.34 (m, 14H,
overlapping peaks). 13C{1H} NMR (50 MHz, CDCl3) δ
137.9, 132.3, 128.8, 128.6, 128.1, 123.6, 90.3, 86.4, 59.5,
47.2, 35.8, 26.6, 25.8, 24.8, 23.2, 21.3.[81]
1-(1-(phenylethynyl)cyclopentyl)pyrrolidine
(4d):
Prepared according to the general procedure and obtained
as an orange/yellow oil in 75% yield (359 mg, 1.50 mmol).
1H NMR (200 MHz, CDCl3) δ 7.48 – 7.35 (m, 2H), 7.33 –
7.17 (m, 3H), 2.88 – 2.61 (t, J = 6.7 Hz, 4H), 2.21 – 1.98
(m, 2H), 1.93 – 1.64 (m, 10H, overlapping peaks). 13C{1H}
1-(1-(p-tolylethynyl)cyclohexyl)piperidine (4o): Prepared
according to the general procedure and obtained as a
1
yellow oil in 70% yield (394 mg, 1.40 mmol). H NMR
10
This article is protected by copyright. All rights reserved.